Chemotherapy and survival in colorectal cancer patients with and without microsatellite instability: can MSI be a prognostic marker?

Gastroenterology. 2004 Aug;127(2):688-9; author reply 689-90. doi: 10.1053/j.gastro.2004.06.039.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Colorectal Neoplasms* / drug therapy
  • Colorectal Neoplasms* / genetics
  • Colorectal Neoplasms* / mortality
  • Fluorouracil / therapeutic use*
  • Humans
  • Microsatellite Repeats*
  • Prognosis

Substances

  • Antimetabolites, Antineoplastic
  • Fluorouracil